Brief: Elicera Therapeutics Enters Agreement With Baylor College Of Medicine

Elicera Therapeutics AB

15/12/2021 09:17

Dec 15 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ELICERA THERAPEUTICS ENTERS INTO AGREEMENT WITH BAYLOR
COLLEGE
OF MEDICINE FOR CONTRACT MANUFACTURING OF NEXT GENERATION
ONCOLYTIC VIRUS, ELC-201
    * HAS SIGNED AN AGREEMENT WITH BAYLOR COLLEGE OF MEDICINE
(BCM),
CENTER FOR CELL & GENE THERAPY REGULATING CONTRACT MANUFACTURING
OF ELC-201
    * PRODUCTION IS PLANNED TO BE COMPLETED BY MID 2023

Source text for Eikon:  ID:nWkr8KVytd 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))